CREATIVE BIOMART RECOMBINANT PROTEINS

Dead / Cancelled — Cancelled — Section 8 (as of 18 Aug 2023)

What this means for you

This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
87066966
Registration number
5136522
Mark type
Design + words
Filed
10 Jun 2016
Published for opposition
22 Nov 2016
Registered
07 Feb 2017
Attorney of record
David Lin

Goods and services

  • Class 042 — Scientific and technological services: Bacteriological consultation and research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Chemist services; Chemistry consultation; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; DNA analysis services for scientific research purposes; Drug discovery services; Executing of chemical analyses; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Laboratory analysis in the field of bacteriology, chemistry, and cosmetics; Laboratory research services relating to pharmaceuticals; Laboratory services, namely, pigment and color analysis; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research information in the field of drug discovery; Medical laboratory services; Medical research; Medical research services in the field of cancer; Performance of chemical analyses; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product testing; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development in the field of drug discovery; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of drug discovery; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research and development; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of drug discovery, medicine, the prevention, treatment and management of illness, health care delivery, and cancerous diseases; Scientific research in the field of genetics and genetic engineering

Owner

Prosecution history

  • 18 Aug 2023 — CANCELLED SEC. 8 (6-YR)
  • 07 Feb 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 08 Oct 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 07 Feb 2017 — REGISTERED-PRINCIPAL REGISTER
  • 22 Nov 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 22 Nov 2016 — PUBLISHED FOR OPPOSITION
  • 02 Nov 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 15 Oct 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED
  • 15 Oct 2016 — ASSIGNED TO LIE
  • 29 Sept 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 27 Sept 2016 — EXAMINER'S AMENDMENT ENTERED
  • 27 Sept 2016 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 27 Sept 2016 — EXAMINERS AMENDMENT E-MAILED
  • 27 Sept 2016 — EXAMINERS AMENDMENT -WRITTEN
  • 21 Sept 2016 — ASSIGNED TO EXAMINER

View this trademark record on Marksy